Molecular genetics and clinical applications for RH
- PMID: 21277262
- PMCID: PMC3042511
- DOI: 10.1016/j.transci.2010.12.013
Molecular genetics and clinical applications for RH
Abstract
Rhesus is the clinically most important protein-based blood group system. It represents the largest number of antigens and the most complex genetics of the 30 known blood group systems. The RHD and RHCE genes are strongly homologous. Some genetic complexity is explained by their close chromosomal proximity and unusual orientation, with their tail ends facing each other. The antigens are expressed by the RhD and the RhCE proteins. Rhesus exemplifies the correlation of genotype and phenotype, facilitating the understanding of general genetic mechanisms. For clinical purposes, genetic diagnostics of Rhesus antigens will improve the cost-effective development of transfusion medicine.
Published by Elsevier Ltd.
Conflict of interest statement
Figures




References
-
- Denomme GA, Flegel WA. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion. 2008 Nov;48(11):2461–2475. - PubMed
-
- Hillyer CD, Shaz BH, Winkler AM, Reid M. Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services. Transfus.Med.Rev. 2008 Apr;22(2):117–132. - PubMed
-
- Westhoff CM. The potential of blood group genotyping for transfusion medicine practice. Immunohematology. 2008;24(4):190–195. - PubMed
-
- Avent ND. Large-scale blood group genotyping: clinical implications. Br.J.Haematol. 2009 Jan;144(1):3–13. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical